ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
3,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
7,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
8,1,Death neonatal,Death and sudden death,Fatal outcomes,Genrl,Y
8,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
9,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
9,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
10,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
10,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
10,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
11,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11,2,Pulmonary haemorrhage neonatal,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,Y
12,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
12,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
13,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
14,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
15,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
16,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
17,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
17,2,Cyanosis neonatal,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
17,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
17,4,Neonatal pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
17,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
17,6,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
17,7,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
18,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
19,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
20,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
21,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
22,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
23,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
24,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
25,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
26,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
27,1,Endotracheal intubation complication,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
27,2,Tracheal injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
28,1,Neonatal dyspnoea,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
28,2,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
29,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Perforation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
30,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
30,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
31,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
32,1,Neonatal hypoxia,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
33,1,Neonatal hypoxia,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
34,1,Neonatal hypoxia,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
35,1,Neonatal hypoxia,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
36,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
36,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
37,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
37,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
37,3,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
38,1,Neonatal pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
39,1,Neonatal pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
